Wells Pharma Of Houston Llc: Fentanyl Citrate Injectable Solution In 0.9% Sodium Chloride, 1000 Mcg/50ml (20 Mcg Per Ml), Well Pharma Of Houston

Wells Pharma of Houston LLC is recalling fentanyl citrate injectable solution (1000 mcg/50mL vials) distributed nationwide because the manufacturer did not follow required manufacturing standards (cGMP deviations). This is a Class II recall, meaning use of the product could cause serious health problems or death. The recall affects hospitals, clinics, and other healthcare facilities across all U.S. states that received this medication.

Recalling firm
Wells Pharma of Houston LLC
Product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Reason
cGMP deviations.
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-04-01
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
U.S. Nationwide.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/ab8745cb-0d9a-4c58-848e-5eac1d21d8b0